Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Protein Science : a Publication of the Protein Society
|
July 31, 2007
Loopholes and missing links in protein modeling
Karen A Rossi, Carolyn A Weigelt, Akbar Nayeem, et al.
Journal of Computer-Aided Molecular Design
|
May 22, 2009
Closing the side-chain gap in protein loop modeling
Karen A Rossi, Akbar Nayeem, Carolyn A Weigelt, et al.
Archives of Biochemistry and Biophysics
|
December 21, 2005
Mechanism of Gly-Pro-pNA cleavage catalyzed by dipeptidyl peptidase-IV and its inhibition by saxagliptin (BMS-477118)
Young B Kim, Lisa M Kopcho, Mark S Kirby, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 14, 2010
Synthesis, SAR, and atropisomerism of imidazolopyrimidine DPP4 inhibitors
Stephen P O'Connor, Ying Wang, Ligaya M Simpkins, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 31, 2003
Synthesis and biological evaluation of nonpeptide integrin antagonists containing spirocyclic scaffolds
Joanne M Smallheer, Carolyn A Weigelt, Francis J Woerner, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 18, 2015
Design and synthesis of potent, selective phenylimidazole-based FVIIa inhibitors
Peter W Glunz, Xuhong Cheng, Daniel L Cheney, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 9, 2020
Annulation reaction enables the identification of an exocyclic amide tricyclic chemotype as retinoic acid Receptor-Related orphan receptor gamma (RORγ/RORc) inverse agonists
David Marcoux, Myra Beaudoin Bertrand, Carolyn A Weigelt, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 1, 2020
Discovery of 2,6-difluorobenzyl ether series of phenyl ((R)-3-phenylpyrrolidin-3-yl)sulfones as surprisingly potent, selective and orally bioavailable RORγt inverse agonists
James J-W Duan, Bin Jiang, Zhonghui Lu, et al.
Journal of Medicinal Chemistry
|
August 6, 2010
Discovery of 6-(aminomethyl)-5-(2,4-dichlorophenyl)-7-methylimidazo[1,2-a]pyrimidine-2-carboxamides as potent, selective dipeptidyl peptidase-4 (DPP4) inhibitors
Wei Meng, Robert P Brigance, Hannguang J Chao, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 13, 2013
Nonbenzamidine acylsulfonamide tissue factor-factor VIIa inhibitors
Peter W Glunz, Xiaojun Zhang, Yan Zou, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Protein Science : a Publication of the Protein Society
|
July 31, 2007
Loopholes and missing links in protein modeling
Karen A Rossi, Carolyn A Weigelt, Akbar Nayeem, et al.
Journal of Computer-Aided Molecular Design
|
May 22, 2009
Closing the side-chain gap in protein loop modeling
Karen A Rossi, Akbar Nayeem, Carolyn A Weigelt, et al.
Archives of Biochemistry and Biophysics
|
December 21, 2005
Mechanism of Gly-Pro-pNA cleavage catalyzed by dipeptidyl peptidase-IV and its inhibition by saxagliptin (BMS-477118)
Young B Kim, Lisa M Kopcho, Mark S Kirby, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 14, 2010
Synthesis, SAR, and atropisomerism of imidazolopyrimidine DPP4 inhibitors
Stephen P O'Connor, Ying Wang, Ligaya M Simpkins, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 31, 2003
Synthesis and biological evaluation of nonpeptide integrin antagonists containing spirocyclic scaffolds
Joanne M Smallheer, Carolyn A Weigelt, Francis J Woerner, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 18, 2015
Design and synthesis of potent, selective phenylimidazole-based FVIIa inhibitors
Peter W Glunz, Xuhong Cheng, Daniel L Cheney, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 9, 2020
Annulation reaction enables the identification of an exocyclic amide tricyclic chemotype as retinoic acid Receptor-Related orphan receptor gamma (RORγ/RORc) inverse agonists
David Marcoux, Myra Beaudoin Bertrand, Carolyn A Weigelt, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 1, 2020
Discovery of 2,6-difluorobenzyl ether series of phenyl ((R)-3-phenylpyrrolidin-3-yl)sulfones as surprisingly potent, selective and orally bioavailable RORγt inverse agonists
James J-W Duan, Bin Jiang, Zhonghui Lu, et al.
Journal of Medicinal Chemistry
|
August 6, 2010
Discovery of 6-(aminomethyl)-5-(2,4-dichlorophenyl)-7-methylimidazo[1,2-a]pyrimidine-2-carboxamides as potent, selective dipeptidyl peptidase-4 (DPP4) inhibitors
Wei Meng, Robert P Brigance, Hannguang J Chao, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 13, 2013
Nonbenzamidine acylsulfonamide tissue factor-factor VIIa inhibitors
Peter W Glunz, Xiaojun Zhang, Yan Zou, et al.
Page
of 3